KRTAP5 inhibitors are a class of chemical compounds designed to specifically interfere with the function of keratin-associated protein 5 (KRTAP5). KRTAPs, including the KRTAP5 family, play a critical role in the structure and organization of keratin, a fibrous protein that forms the main component of hair, nails, and the outer layer of skin. KRTAP5 proteins are part of a large multigene family and are particularly involved in the formation of the hair shaft, where they regulate the assembly and rigidity of keratin filaments. The inhibition of KRTAP5 disrupts the normal assembly of these keratin fibers, affecting the structural properties of keratinized tissues. By targeting these proteins, inhibitors can modulate the structural interactions between KRTAP5 and keratin, potentially leading to changes in the overall stability and organization of keratin networks.
Chemically, KRTAP5 inhibitors may interact with key functional domains in the KRTAP5 protein that are responsible for binding to keratin or other structural proteins. These inhibitors could act through direct binding to KRTAP5, leading to conformational changes that prevent its normal interaction with keratin. Alternatively, they may interfere with post-translational modifications or signaling pathways that regulate KRTAP5 expression or function. The structure of KRTAP5 inhibitors can vary widely, encompassing small organic molecules, peptides, or other synthetic compounds designed to bind with high specificity to the protein. By inhibiting KRTAP5 function, these compounds can provide insights into the mechanisms of keratin assembly and its role in maintaining the integrity of keratin-based structures.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D may inhibit KRTAP5 expression by intercalating into DNA, blocking RNA synthesis and affecting transcription of KRTAP5. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide might inhibit KRTAP5 expression by blocking protein synthesis, thereby reducing the production of KRTAP5 protein. | ||||||
Chromomycin A3 | 7059-24-7 | sc-200907 | 10 mg | $260.00 | ||
Actinomycin C could potentially inhibit KRTAP5 expression similarly to Actinomycin D, by interfering with RNA synthesis. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $97.00 $328.00 $676.00 $1467.00 | 6 | |
Rifampicin may inhibit KRTAP5 expression by targeting bacterial-like RNA polymerase, potentially affecting the transcription of KRTAP5. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $166.00 $322.00 | 436 | |
Puromycin might inhibit KRTAP5 expression by prematurely terminating protein synthesis, thereby reducing KRTAP5 production. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin has been suggested to inhibit KRTAP5 expression by inhibiting protein synthesis at the translational level, affecting KRTAP5 production. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Doxorubicin may inhibit KRTAP5 expression by intercalating into DNA and impacting transcription, reducing the synthesis of KRTAP5. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Etoposide could potentially inhibit KRTAP5 expression by affecting topoisomerase II activity, influencing DNA transcription and KRTAP5 synthesis. | ||||||
Blasticidin S Hydrochloride | 3513-03-9 | sc-204655A sc-204655 | 25 mg 100 mg | $367.00 $520.00 | 20 | |
Blasticidin S may inhibit KRTAP5 expression by interfering with protein synthesis, potentially reducing the production of KRTAP5. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $66.00 $101.00 $143.00 | 85 | |
Mitomycin C might inhibit KRTAP5 expression by crosslinking DNA, affecting transcription and potentially reducing KRTAP5 synthesis. | ||||||